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Abstract
Background: Whether excess body weight influences colorectal cancer (CRC) survival is unclear. We studied
pre-diagnostic body mass index (BMI) and weight change in relation to CRC-specific mortality among incident CRC
cases within a large, Norwegian cohort.
Methods: Participants’ weight was measured at health examinations up to three times between 1974 and 1988.
CRC cases were identified through linkage with the Norwegian Cancer Registry. In total, 1336 men and 1180
women with a weight measurement >3 years prior to diagnosis were included in analyses. Hazard ratios (HRs) and
confidence intervals (CIs) were estimated with Cox regression.
Results: During a mean follow-up of 5.8 years, 507 men and 432 women died from CRC. Obesity (BMI ≥30 kg/m2)
was associated with higher CRC-specific mortality than normal weight (BMI 18.5–25 kg/m2) in men with proximal
colon cancer, HR = 1.85 (95 % CI 1.08–3.16) and in women with rectal cancer, HR = 1.93 (95 % CI 1.13–3.30). Weight
gain was associated with higher CRC-specific mortality in women with CRC, colon cancer, and distal colon cancer,
HRs per 5 kg weight gain were 1.18 (95 % CI 1.01–1.37), 1.22 (95 % CI 1.02–1.45), and 1.40 (95 % CI 1.01–1.95),
respectively. Weight gain was not significantly associated with survival in men.
Conclusions: Maintaining a healthy weight may benefit CRC survival, at least in women.
Keywords: Colorectal cancer, Survival, Body mass index, Weight change, Cohort study
Background
Excess body weight is an established risk factor for colo-
rectal cancer (CRC) in both men and women, and a
positive association between body mass index (BMI) and
CRC incidence has been found in numerous studies [1].
The association is stronger in men than in women and
stronger for colon than for rectal cancers [1]. Further-
more, the association seems to be stronger for distal
than for proximal colon cancers [2]. These observations
support that the biological mechanisms operating may
vary by sex and colorectal subsite.
Less is known about the influence of excess body
weight on CRC survival. However, it is possible that the
mechanisms linking excess body weight to development
of CRC tumors, related to e.g. insulin, insulin-like
growth factors, inflammation, and steroid hormones,
also influence tumor progression and thereby survival of
the disease [3, 4]. Some studies have evaluated the asso-
ciation between BMI at the time of treatment, i.e.
around the time of diagnosis, and survival after colon
[5–7] or rectal cancer [8, 9], but the results are difficult
to interpret since weight loss is a clinical feature of CRC
[10]. Thus, the patients’ weight might be a consequence
of the disease itself (‘reverse causation’). Moreover,
whether maintaining a healthy weight throughout adult-
hood is important not only for CRC prevention, but also
for CRC survival, is not clear from these studies. Pre-
* Correspondence: ida.laake@fhi.no
1Oslo Centre for Biostatistics and Epidemiology, Institute of Basic Medical
Sciences, University of Oslo, Oslo, Norway
2Department of Vaccines, Norwegian Institute of Public Health, Oslo, Norway
Full list of author information is available at the end of the article
© 2016 The Author(s). Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Laake et al. BMC Cancer  (2016) 16:402 
DOI 10.1186/s12885-016-2445-4
diagnostic BMI is probably a better marker of weight
across life-course than BMI at the time of diagnosis.
A recent meta-analysis found that pre-diagnostic obes-
ity (BMI ≥30 kg/m2) was significantly associated with
poorer survival after CRC [11]. However, this meta-
analysis only presented results for men and women
combined and for CRC overall. Few of the studies that
have evaluated the association between pre-diagnostic
BMI and CRC survival have examined whether results
differ for men and women [12–17] or between CRC sub-
sites [12–14, 17–21]. Finally, although adult weight gain
is related to increased colon cancer risk [22], only one
study has examined pre-diagnostic weight change and
survival after CRC [17].
We have previously studied BMI and weight change
in relation to colon cancer risk in the Norwegian
Counties Study [23]. The aim of the present study was
to examine sex-specific and subsite-specific associa-
tions between BMI and weight change measured prior
to diagnosis and survival among incident CRC cases
from this cohort.
Methods
The Norwegian counties study
The Norwegian Counties Study is a population-based
Norwegian cohort study described in detail elsewhere
[23, 24]. In short, participants were examined by a team
of trained nurses at health screenings up to three times
between 1974 and 1988. The attendance rate was >80 %
at all three screenings, and 92,234 men and women
attended at least one screening. At each screening, the
participants’ height was measured to the nearest centi-
meter and weight to the nearest 0.5 kilo. Information on
lifestyle factors such as smoking habits and recreational
and occupational physical activity during the last year
was collected with a questionnaire.
Using the unique personal identification number
assigned to all Norwegian citizens, information on each
participant’s education was obtained from records of the
censuses in 1970, 1980, 1990, and 2001. The most recent
information available was used.
Case identification
CRC cases were identified through linkage with the Cancer
Registry of Norway, i.e. cancers coded as 153 or 154 ac-
cording to the International Classification of Diseases,
Seventh edition (ICD-7). The cases were categorized as
colon cancer (ICD-7: 153) or rectal cancer (ICD-7: 154).
Furthermore, cancers of the appendix, cecum, ascending
or transverse colon (including the hepatic and splenic flex-
ures) (153.0, 153.1, and 153.6) were categorized as prox-
imal colon cancer. Cancers that occurred in the
descending colon, sigmoid colon, or rectosigmoid junction
(153.2 − 153.4) were categorized as distal colon cancer.
We only considered the first cancer diagnosis. Participants
diagnosed with multiple malignant tumors at the date of
first diagnosis were included as CRC cases if all the can-
cers occurred in the colorectum. Correspondingly, mul-
tiple cancers were included as a cancer of one of the
subsites (colon, proximal colon, distal colon, or rectum) if
they all occurred in the same subsite. The cases were clas-
sified according to stage at diagnosis as localized, regional,
or distant. For participants with multiple malignant tu-
mors, stage at diagnosis was defined as the stage of the
most advanced.
We identified 2786 cases of CRC among the cohort
participants. Of these, 69 were diagnosed with multiple
malignant tumors.
Study sample
For each case, we obtained information on weight,
smoking, and physical activity level from the most recent
screening. This screening was defined as the case’s ex-
posure screening if 1) no information was missing and
2) the screening took place at least 3 years prior to diag-
nosis. Otherwise, the most recent preceding screening
fulfilling these requirements was defined as the exposure
screening. Pre-diagnostic BMI (kg/m2) was calculated as
weight at the exposure screening divided by height
squared, using the mean height from all attended screen-
ings. We excluded 54 cases with missing information on
weight, smoking, and physical activity at all three screen-
ings, 35 cases diagnosed before information was col-
lected, and 44 cases diagnosed <3 years after the
information was collected. We furthermore excluded 5
cases with no height measurements and 6 cases without
information on education. We also excluded 23 cases
with BMI <18.5 kg/m2 at the exposure screening due to
concerns that their weight was influenced by pre-
existing CRC or other underlying health problems that
may influence survival. Finally, we excluded 97 cases
with unknown stage at diagnosis, 2 cases with date of
diagnosis equal to date of death, and 4 cases with date of
emigration prior to their date of diagnosis.
In total, 2516 CRC cases, 1336 men and 1180 women,
diagnosed between 1978 and 2012, were included in
analyses of BMI and CRC survival (Additional file 1 :
Figure S1). In men, 847 of the cases were colon cancers,
of which 443 occurred in the proximal and 369 in the
distal colon, and 478 cases were rectal cancers. In
women, 808 cases were colon cancers, 493 were prox-
imal colon cancers, 294 were distal colon cancers, and
367 were rectal cancers.
For analyses of weight change, we furthermore ex-
cluded 622 cases with no weight measurements prior to
the exposure screening, leaving 999 men (637 colon can-
cers, 339 proximal colon cancers, 270 distal colon can-
cers, 351 rectal cancers) and 895 women (608 colon
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cancers, 383 proximal colon cancers, 207 distal colon
cancers, 283 rectal cancers) (Additional file 2: Figure
S2).
We determined the power of detecting an effect esti-
mate per 5 unit increase in BMI of 1.20 with a signifi-
cance level of 0.05 in our study sample [25]. We used
the standard deviation of BMI among CRC cases, 3.2 kg/
m2 in men and 4.5 kg/m2 in women. In men, the power
was 0.87 for CRC, 0.69 for colon cancer, 0.41 for prox-
imal colon cancer, 0.31 for distal colon cancer, and 0.46
for rectal cancer. In women, the power was 0.97, 0.87,
0.68, 0.45, and 0.60 for CRC, colon cancer, proximal
colon cancer, distal colon cancer, and rectal cancer,
respectively.
The cases were followed from the date of diagnosis
until death, emigration, or December 31, 2012. Informa-
tion on death and emigration was obtained from the
Cause of Death Registry and the National Population
Registry. CRC-related death was the primary outcome
and death from all causes was the secondary outcome.
Deaths with cause 153–154 (ICD-8 and ICD-9) or C18–21
(ICD-10) were considered CRC-related deaths.
Statistical analysis
Pre-diagnostic BMI was categorized according to
WHO guidelines: 18.5 − 24.9 kg/m2 (normal weight),
25 − 29.9 kg/m2 (overweight), and ≥30 kg/m2 (obese)
[26]. Weight change was defined as weight at the exposure
screening minus initial weight, i.e., weight at the first
attended screening, and was categorized as ≤−2.0 kg
(weight loss), −1.9 − 1.9 kg (weight maintenance),
2.0–7.9 kg (moderate weight gain), and ≥8.0 kg
(large weight gain).
We examined BMI and weight change in relation to
risk of death from CRC, our primary outcome, and risk
of death from all causes. Hazard ratios (HRs) and 95 %
confidence intervals (CIs) were estimated with Cox re-
gression. We used a stratified Cox model with stage of
disease at diagnosis as the strata (localized, regional, or
distant) and time since diagnosis as the time variable.
We adjusted for smoking (never, former, current) and
level of recreational and occupational physical activity
combined (sedentary, moderately active, or active) [23],
both measured at the exposure screening, education
(primary schooling (≤9 years), secondary education (10–
12 years), or university level education (≥ 13 years)), age
at diagnosis (continuous) and year of diagnosis (< 1990,
1990–94, 1995–99, 2000–2004, and ≥2005). Analyses of
weight change were also adjusted for initial BMI (con-
tinuous). Adjustment for time between the exposure
screening and diagnosis did not change the results and
was not included in the model. To test for trend, BMI/
weight change was modeled continuously and evaluated
with a Wald test. All analyses with continuous weight
change were restricted to subjects who maintained or
gained weight because we hypothesized that weight loss
may cause a J or U-shaped relation. We furthermore
tested whether the associations with CRC-specific
mortality differed in the colon and rectum or in the
proximal and distal colon by testing the difference in
trends with a Wald statistic. To assess whether associa-
tions differed with sex, we included interaction terms
between sex and BMI (continuous) or between sex and
weight gain (continuous). For CRC, we also examined
whether the association between weight gain (con-
tinuous) and mortality differed with initial BMI
(<25 kg/m2 and ≥25 kg/m2). Tests of interaction
were evaluated with a likelihood ratio test and were
done for CRC-specific mortality only. Proportional haz-
ards assumptions were evaluated with a test based on
the Schoenfeld residuals. The tests did not indicate vio-
lations of the assumption. All tests were two sided, and
P < 0.05 was considered statistically significant. The ana-




Mean age at diagnosis in the BMI study sample (n =
2516) was 66.4 years (range 32.0–85.6) in men and
66.8 years (range 36.0–86.4) in women. During a mean
follow-up of 5.8 years, 703 men and 543 women died.
Of these, 507 men and 432 women died from CRC.
Time from BMI measurement to diagnosis ranged from
3.0 to 37.5 years (mean 17.8 years). Mean pre-diagnostic
BMI was similar in men and women, 26.0 kg/m2 and
25.7 kg/m2, respectively. For both men and women, the
proportion with a university education was highest
among those with normal weight (Table 1). With in-
creasing BMI, the proportion of sedentary subjects in-
creased, the proportion of current smokers decreased,
and mean systolic blood pressure increased. Further-
more, age at diagnosis increased and the proportion with
distant stage disease decreased with increasing BMI in
women.
In men with proximal colon cancer, pre-diagnostic
obesity was associated with higher risk of CRC-related
death than normal weight, HR = 1.85 (95 % CI 1.08–
3.16) (Table 2). BMI was not significantly associated with
CRC-specific mortality in men with CRC, colon cancer,
distal colon cancer, or rectal cancer. In women, we
found no significant associations between BMI and risk
of CRC-related death after diagnosis of CRC or cancer
of any colon subsite. However, obese women had signifi-
cantly increased risk of CRC-related death after diagno-
sis of rectal cancer, HR = 1.93 (95 % CI 1.13–3.30). We
found no significant interactions between BMI and sex
(Pinteraction ≥ 0.26). The associations between BMI and
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risk of CRC-related death did not differ significantly with
subsite: colon vs. rectum (Pheterogeneity ≥ 0.27), proximal
vs. distal colon (Pheterogeneity ≥ 0.33). In contrast with the
results on CRC-related death, pre-diagnostic obesity was
associated with higher all-cause mortality in men with
CRC and colon cancer (Additional file 3: Table S1). In
women, associations between pre-diagnostic BMI and
all-cause mortality were similar to the associations found
for CRC-specific mortality.
Weight change
In the weight change study sample (n = 1894), 533 men
and 414 women died during follow-up. Of these, 372
men and 326 women died from CRC. Mean weight
change was 2.5 kg in men and 2.0 kg in women. Cases
who lost weight prior to diagnosis had a higher initial
BMI and were more likely to be current smokers than
cases who maintained or gained weight (Table 3). Fur-
thermore, the highest proportion of sedentary subjects
was found among those who gained ≥8 kg. In men, the
proportion with distant stage disease was lowest among
those who had maintained their weight and the propor-
tion increased with increasing weight gain, whereas in
women the proportion with distant stage disease de-
creased with increasing weight gain.
Pre-diagnostic weight gain was not significantly related
to CRC-specific mortality in men, but weight loss was
associated with significantly increased risk of CRC-
related death compared to weight maintenance in men
with rectal cancer, HR = 1.78 (95 % CI 1.06–3.00)
(Table 4). In women, weight gain was significantly associ-
ated with increased risk of death from CRC after diagnosis
of CRC, HR = 1.18 (95 % CI 1.01–1.37) per 5 kg weight
gain, Ptrend = 0.03. Moreover, in women with colon cancer,
moderate and large weight gain were both associated
with significantly increased risk of CRC-related death
compared to weight maintenance, HRs = 1.54 (95 % CI
1.08–2.20) and 1.64 (95 % CI 1.03–2.63), respectively,
Ptrend = 0.03. For proximal colon cancer, we observed
increased risk in women with moderate weight gain,
HR = 1.59 (95 % CI 1.01–2.49), but not in women with
large weight gain. In women with distal colon cancer,
large weight gain was associated with significant, increased
risk of CRC-related death compared to weight mainten-
ance, HR = 2.99 (95 % CI 1.27–7.05), Ptrend = 0.04. Weight
change was not associated with CRC-specific mortal-
ity in women with rectal cancer. No significant inter-
actions between weight gain and sex were observed
(Pinteraction ≥ 0.18). The associations did not differ sig-
nificantly with subsite; colon vs. rectum (Pheterogeneity ≥ 0.38),
proximal vs. distal colon (Pheterogeneity ≥ 0.12). We did not
observe significant interactions between BMI and weight
gain (Pinteraction ≥ 0.33). The results on all-cause mortality
were similar to the results on CRC-specific mortality,
Table 1 Characteristics of CRC cases by pre-diagnostic BMI, n = 2516
MEN WOMEN
BMI (kg/m2) BMI (kg/m2)
18.5–24.9 25–29.9 ≥30 18.5–24.9 25–29.9 ≥30
Number of cases 544 662 130 626 366 188
Follow-up (years), mean 6.1 5.4 5.5 6.1 5.9 5.7
University level education (%) 13.8 12.7 8.5 12.0 6.8 7.4
Current smokers (%)a 51.1 38.5 35.4 46.0 32.5 22.9
Sedentary (%)a 26.5 26.9 36.2 27.5 32.0 35.6
Systolic blood pressure (mmHg)a, mean 134 138 145 128 137 145
Exposure screening (%)
Screening 1 7.2 7.4 1.5 9.6 3.3 8.0
Screening 2 29.6 26.9 30.0 29.9 27.9 22.9
Screening 3 63.2 65.7 68.5 60.5 68.9 69.1
Age at exposure screening (years), mean 47.9 49.1 49.5 47.8 50.3 50.7
Time between exposure screening and
diagnosis (years), mean
17.7 18.2 15.6 18.1 17.5 17.6
Age at diagnosis (years), mean 65.6 67.3 65.1 65.8 67.9 68.2
Stage at diagnosis (%)
Localized 24.3 24.6 22.3 27.0 25.7 26.6
Regional 52.4 48.5 52.3 46.3 50.5 53.7
Distant 23.3 26.9 25.4 26.7 23.8 19.7
a At exposure screening
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Table 2 Hazard ratios and 95 % confidence intervals for CRC-specific mortality by pre-diagnostic BMI
BMI (kg/m2)
18.5–24.9 25–29.9 ≥30 Per 5 kg/m2 Ptrend
a
MEN
CRC, n = 1336
Person-years 3320 3563 710
Number of CRC-related deaths 198 254 55
HR (95 % CI)b 1 (Ref) 0.98 (0.81, 1.18) 1.01 (0.74, 1.37) 0.99 (0.86, 1.14) 0.87
Colon cancer, n = 847
Person-years 1936 2144 433
Number of CRC-related deaths 125 158 39
HR (95 % CI)b 1 (Ref) 1.02 (0.80, 1.30) 1.26 (0.87, 1.83) 1.07 (0.90, 1.28) 0.43
Proximal colon cancer, n = 443
Person-years 1072 1058 160
Number of CRC-related deaths 63 80 19
HR (95 % CI)b 1 (Ref) 1.17 (0.82, 1.66) 1.85 (1.08, 3.16) 1.19 (0.93, 1.54) 0.17
Distal colon cancer, n = 369
Person-years 848 996 272
Number of CRC-related deaths 53 65 18
HR (95 % CI)b 1 (Ref) 0.91 (0.63, 1.33) 0.91 (0.52, 1.59) 0.98 (0.75, 1.30) 0.91
Rectal cancer, n = 478
Person-years 1374 1371 273
Number of CRC-related deaths 73 94 16
HR (95 % CI)b 1 (Ref) 0.99 (0.71, 1.37) 0.75 (0.43, 1.33) 0.93 (0.73, 1.17) 0.52
WOMEN
CRC, n = 1180
Person-years 3793 2175 1064
Number of CRC-related deaths 220 138 74
HR (95 % CI)b 1 (Ref) 1.07 (0.85, 1.33) 1.31 (0.99, 1.72) 1.04 (0.93, 1.17) 0.51
Colon cancer, n = 808
Person-years 2469 1386 760
Number of CRC-related deaths 153 90 50
HR (95 % CI)b 1 (Ref) 0.97 (0.74, 1.27) 1.25 (0.89, 1.74) 1.02 (0.89, 1.18) 0.75
Proximal colon cancer, n = 493
Person-years 1279 876 372
Number of CRC-related deaths 93 53 29
HR (95 % CI)b 1 (Ref) 0.89 (0.63, 1.28) 1.23 (0.80, 1.91) 1.02 (0.84, 1.24) 0.82
Distal colon cancer, n = 294
Person-years 1160 467 369
Number of CRC-related deaths 54 34 17
HR (95 % CI)b 1 (Ref) 1.33 (0.84, 2.11) 1.18 (0.64, 2.16) 1.06 (0.83, 1.35) 0.65
Rectal cancer, n = 367
Person-years 1271 788 283
Number of CRC-related deaths 67 47 24
HR (95 % CI)b 1 (Ref) 1.42 (0.95, 2.13) 1.93 (1.13, 3.30) 1.18 (0.96, 1.47) 0.12
a Wald P-value for BMI as continuous variable
b Stratified Cox model (year of diagnosis: < 1990, 1990–1994, 1995–1999, 2000–2004, ≥ 2005). Adjustment for age at diagnosis, stage of disease at diagnosis (localized,
regional, or distant), smoking (never, former, or current), physical activity level (sedentary, moderately active, or active), education (≤ 9, 10-12, or≥ 13 years)
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except that weight gain was not significantly associated
with higher all-cause mortality in women with CRC over-
all (Additional file 4: Table S2).
Discussion
In this study, obesity prior to diagnosis was significantly
associated with higher CRC-specific mortality in men
with proximal cancer and in women with rectal cancer.
Furthermore, pre-diagnostic weight gain was signifi-
cantly associated with higher CRC-specific mortality in
women with CRC, colon cancer, proximal colon cancer,
or distal colon cancer. Weight gain was not related to
CRC-specific mortality in men. However, men with rec-
tal cancer who had lost weight prior to diagnosis had in-
creased risk of CRC-related death.
The association between BMI and CRC risk is stronger
in men than in women [1], but whether there are sex
differences regarding excess body weight and survival
after CRC is not known. Our results did not indicate a
stronger association in men. Results from previous stud-
ies are inconsistent. Men who were obese prior to diag-
nosis of CRC have been found to have poorer survival
[14], while other studies have found weak or no associa-
tions [13, 15, 16, 27]. Likewise, both significantly poorer
survival [12, 17, 19] and no associations [14, 16, 28]
have been found in women who were obese prior to
CRC diagnosis. Differences between the cases in these
studies in terms of e.g. age at diagnosis, stage of dis-
ease, treatment, and subsite distribution may explain
the disparities in the results. Another possible explan-
ation is differences in the timing of BMI measurement
in relation to diagnosis which may also influence the
results.
We expected to find stronger associations between
BMI and survival for colon cancer than for rectal cancer.
However, in women, the opposite was observed. Results
from previous studies are inconsistent. Pre-diagnostic
obesity has been found to be associated with signifi-
cantly poorer survival after both colon [14, 17, 19–21]
and rectal cancer [12–14, 17], but no association with
survival after colon cancer [13, 29] or after rectal cancer
[19, 21] has also been reported. Only two studies have
presented results on pre-diagnostic BMI in relation to
survival after cancer in subsites of the colon [14, 18].
These studies found that BMI was significantly associ-
ated with poorer survival after distal colon cancer,
whereas a non-significant association was found for
proximal colon cancer [14, 18]. Subsite-differences in
the association between BMI and survival after diagno-
sis of CRC may be related to molecular features of CRC
tumors. Microsatellite instable tumors tend to be prox-
imal and are associated with better survival than micro-
satellite stable tumors [30]. Moreover, BMI has been
found to be associated with an increased risk of
Table 3 Characteristics of CRC cases by pre-diagnostic weight change, n = 1894
MEN WOMEN
Weight change (kg) Weight change (kg)
≤−2 −1.9–1.9 2.0–7.9 ≥8.0 ≤−2 −1.9–1.9 2.0–7.9 ≥8.0
Number of cases 155 295 418 131 194 256 323 122
Follow-up (years), mean 5.4 6.3 5.4 5.3 5.4 6.1 6.3 5.3
Initial BMI (kg/m2), mean 26.5 25.1 24.8 25.8 27.3 24.5 24.3 25.3
University level education (%) 7.1 9.2 12.0 8.4 5.2 7.4 10.5 10.7
Current smokers (%)a 61.9 47.8 34.0 25.2 46.9 39.5 33.1 34.4
Sedentary (%)a 20.0 20.7 26.6 39.7 31.4 21.9 28.5 37.7
Systolic blood pressure (mmHg)a, mean 137 137 138 143 133 134 134 141
Exposure screening (%)
Screening 2 31.6 42.7 31.3 14.5 39.2 44.5 30.7 8.2
Screening 3 68.4 57.3 68.7 85.5 60.8 55.5 69.3 91.8
Age at exposure screening (years), mean 50.7 50.8 50.2 50.7 51.3 50.5 51.2 50.8
Time between exposure screening and
diagnosis (years), mean
16.8 17.2 18.0 16.7 18.3 18.1 17.4 16.5
Age at diagnosis (years), mean 67.5 67.9 68.2 67.4 69.6 68.5 68.5 67.3
Stage at diagnosis (%)
Localized 27.1 26.8 23.9 21.4 27.3 27.0 28.2 27.9
Regional 45.8 51.2 52.2 51.9 45.4 48.4 48.6 50.8
Distant 27.1 22.0 23.9 26.7 27.3 24.6 23.2 21.3
a At exposure screening
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Table 4 Hazard ratios and 95 % confidence intervals for CRC-specific mortality by pre-diagnostic weight change
Weight change (kg)
≤−2 −1.9–1.9 2.0–7.9 ≥8.0 Per 5 kga Ptrend
b
MEN
CRC, n = 999
Person-years 836 1844 2240 694
Number of CRC-related deaths 67 109 144 52
HR (95 % CI)c 1.27 (0.93, 1.74) 1 (Ref) 0.95 (0.73, 1.23) 0.93 (0.65, 1.32) 1.01 (0.87, 1.19) 0.86
Colon cancer, n = 637
Person-years 505 1043 1454 360
Number of CRC-related deaths 38 70 92 35
HR (95 % CI)c 0.96 (0.64, 1.44) 1 (Ref) 0.81 (0.59, 1.13) 1.02 (0.66, 1.58) 1.05 (0.86, 1.28) 0.62
Proximal colon cancer, n = 339
Person-years 304 438 833 120
Number of CRC-related deaths 14 38 52 19
HR (95 % CI)c 0.59 (0.31, 1.12) 1 (Ref) 0.66 (0.42, 1.05) 0.77 (0.40, 1.48) 0.88 (0.63, 1.23) 0.46
Distal colon cancer, n = 270
Person-years 195 576 575 224
Number of CRC-related deaths 19 28 33 14
HR (95 % CI)c 1.53 (0.80, 2.93) 1 (Ref) 0.95 (0.55, 1.62) 1.50 (0.75, 3.00) 1.25 (0.94, 1.66) 0.13
Rectal cancer, n = 351
Person-years 330 798 737 325
Number of CRC-related deaths 28 39 51 17
HR (95 % CI)c 1.78 (1.06, 3.00) 1 (Ref) 1.21 (0.78, 1.87) 0.76 (0.40, 1.44) 0.95 (0.74, 1.23) 0.70
WOMEN
CRC, n = 895
Person-years 1049 1562 2034 646
Number of CRC-related deaths 72 91 119 44
HR (95 % CI)c 1.14 (0.82, 1.59) 1 (Ref) 1.33 (1.01, 1.76) 1.41 (0.97, 2.05) 1.18 (1.01, 1.37) 0.03
Colon cancer, n = 608
Person-years 670 1124 1270 473
Number of CRC-related deaths 49 53 85 30
HR (95 % CI)c 1.34 (0.88, 2.02) 1 (Ref) 1.54 (1.08, 2.20) 1.64 (1.03, 2.63) 1.22 (1.02, 1.45) 0.03
Proximal colon cancer, n = 383
Person-years 423 673 645 247
Number of CRC-related deaths 32 33 50 18
HR (95 % CI)c 1.28 (0.76, 2.16) 1 (Ref) 1.59 (1.01, 2.49) 1.49 (0.81, 2.75) 1.18 (0.95, 1.47) 0.14
Distal colon cancer, n = 207
Person-years 231 449 579 197
Number of CRC-related deaths 15 18 29 12
HR (95 % CI)c 1.52 (0.71, 3.25) 1 (Ref) 1.34 (0.69, 2.60) 2.99 (1.27, 7.05) 1.40 (1.01, 1.95) 0.04
Rectal cancer, n = 283
Person-years 379 438 721 173
Number of CRC-related deaths 23 37 34 14
HR (95 % CI)c 0.93 (0.52, 1.64) 1 (Ref) 1.00 (0.60, 1.69) 1.29 (0.67, 2.49) 1.12 (0.82, 1.53) 0.49
a Analyses restricted to cases who maintained or gained weight
b Wald P-value for weight gain as continuous variable
c Stratified Cox model (year of diagnosis: < 1990, 1990–1994, 1995–1999, 2000–2004, ≥2005). Adjustment for age at diagnosis, stage of disease at diagnosis (localized, regional,
distant), smoking (never, former, or current), physical activity level (sedentary, moderately active, or active), education (≤9, 10–12, or ≥13 years), and initial BMI (continuous)
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microsatellite stable tumors, but not microsatellite in-
stable tumors [31, 32].
We found that weight gain before diagnosis of CRC
was related to poorer survival in women, but not in
men. Only one study has previously evaluated pre-
diagnostic weight change in relation to survival after
CRC [17]. In this study, weight gain since age 20 years
was not associated with poorer survival in either men or
women. Weight gain in adulthood is mainly an accumu-
lation of fat mass. The distribution of the accumulated
fat may influence CRC survival, since various fat depots
have different metabolic characteristics [33]. We specu-
late that weight gain may be more strongly related to
harmful fat distribution in women than in men. Also,
the timing of weight gain could be important. Possibly,
weight gain during menopause is especially harmful.
Menopause is associated with an increase in visceral adi-
pose tissue [34], which is particularly related to meta-
bolic disturbances [33]. Many of the women in our study
sample likely became postmenopausal between weight
measurements; median age at the last weight measure-
ment was 51.7 years for women.
Excess body weight may be linked to increased cancer
risk through changes in steroid hormones, insulin,
insulin-like growth factors, leptin and adiponectin, or
pro-inflammatory cytokines [35]. It is possible that such
changes also influence prognosis and survival of cancer,
but the biological role of excess body weight on cancer
survival is under debate. Also, there may have been dif-
ferences between normal weight and obese cases in
terms comorbidities, receipt of optimal treatment and
complications as a result of treatment. Whether this
could explain the associations between obesity and mor-
tality among men with proximal colon cancer and
women with rectal cancer could not be explored in our
study since we did not have information on treatment.
It is of course possible that excess body weight does
not influence survival. Weight gain was associated with
survival across CRC subsites in women, but we did not
observe strong or consistent associations in men. The
significant associations we observed may have been due
to chance. We performed a large number of statistical
tests and would expect to find significant associations
even if BMI and weight change are not related to CRC
survival. However, it is also likely that the causal effect
of obesity and weight change may have been underesti-
mated in our study due to collider-stratification bias
[36]. The study population was selected based on occur-
rence of an event, CRC. Suppose CRC is caused by
both obesity and an uncontrolled risk factor. Then
CRC is a collider, and conditioning on CRC may result
in bias if the uncontrolled risk factor is also a cause of
death [36]. The prevalence of the risk factor may be in-
versely associated with obesity among CRC cases, even
when obesity and the risk factor are unrelated in the
general population. As a consequence, the association
between obesity and risk of death among CRC cases
will be biased towards the null or even reversed [37].
Even though we controlled for several important risk
factors for CRC and death in our analyses, residual
collider-stratification bias cannot be ruled out. How-
ever, it is possible that the magnitude of the bias differs
with sex or CRC subsite. Future studies should attempt
to minimize collider-stratification-bias and must include
detailed information on a large number of common causes
of CRC and death.
Our study was based on CRC cases from a large co-
hort study with a very high attendance rate (80 %).
Through linkage with the Cancer Registry of Norway
we have identified all cases within the cohort. Because
of the prospective design, inclusion of cases did not de-
pend upon duration of survival. Thus, we consider se-
lection bias to be negligible in our study. We cannot
exclude the possibility of reverse causation in our
study, but given the high median length of time be-
tween measurement and diagnosis, weight at the time
of measurement is unlikely to have been influenced by
pre-existing disease for the majority of the cases. Con-
sequently, reverse causation is presumably not a con-
cern in our study. Another important strength is the
accuracy of the exposures. Weight and height were
measured by trained nurses following a strict protocol.
Furthermore, information on weight was collected up
to three times, thus we could study the effect of pre-
diagnostic weight change on CRC survival. We could
also examine sex differences, as our study included
both men and women.
One limitation of our study is the long time between
exposure measurement and diagnosis. Thus, changes
in BMI over time may have occurred. However, mea-
surements of BMI made earlier in life have been found
to be strongly related to measurements later in life [38,
39]. Moreover, additional adjustment for time between
measurement and diagnosis did not change our results.
If fat distribution is important in relation to survival
after CRC, we may have underestimated the effect of
excess body weight, because BMI does not capture fat
distribution. We could not explore whether measures
of abdominal adiposity like waist circumference or
waist-to-hip ratio are more important prognostic fac-
tors than BMI, since we did not have information on
anthropometry beside BMI. Another limitation is that
we could not assess the effect of treatment, a possible
confounder, since we did not have information on type
of treatment the cases received. Finally, we did not
have detailed information on the participants’ diet and
could therefore not adjust for important risk factors
for CRC like intake of red meat and alcoholic drinks.
Laake et al. BMC Cancer  (2016) 16:402 Page 8 of 10
Conclusions
In contrast with what is known about excess body
weight and risk of CRC, we found little evidence of
poorer survival among men who were obese or gained
weight prior to diagnosis of CRC in this study. However,
pre-diagnostic weight gain was related to poorer survival
after CRC in women. Thus, our study supports that hav-
ing maintained a healthy weight throughout adulthood
may be beneficial for CRC survival, at least for women.
The reason for the lack of observed effect in men in our
study is not clear. Potential sex differences must be fur-
ther investigated. Future studies should include detailed
information on treatment and a large number of com-
mon causes of CRC and death.
Additional files
Additional file 1: Figure S1. Flow chart illustrating number of cases in
each colorectal cancer subsite for the BMI study sample. (PDF 38 kb)
Additional file 2: Figure S2. Flow chart illustrating number of cases in
each colorectal cancer subsite for the weight change study sample. (PDF 36 kb)
Additional file 3: Table S1. Hazard ratios and 95% confidence intervals
for all-cause mortality by BMI. (PDF 101 kb)
Additional file 4: Table S2 Hazard ratios and 95% confidence intervals
for all-cause mortality by weight change. (PDF 104 kb)
Abbreviations
BMI, body mass index; CI, confidence interval; CRC, colorectal cancer; HR,




The study did not receive any funding.
Availability of data and materials
The data material consists of sensitive information on an individual level.
Due to protection of privacy and restrictions from the Norwegian Data
Inspectorate and the Regional Committee for Medical and Health Research
Ethics the data are not publicly available.
Authors’ contributions
IL, RS, and MBV conceived of the study. IL performed the statistical analyses
and drafted the manuscript. IKL contributed to interpretation of the data and
helped draft the manuscript. RS and MBV contributed to the statistical
analyses, interpretation of the data, and revised the manuscript critically for
important intellectual content. IT contributed to interpretation of the data
and revised the manuscript critically for important intellectual content. All
authors read and approved the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Consent for publication
Not applicable.
Ethics approval and consent to participate
The present study was approved by the Norwegian Data Inspectorate and
the Regional Committee for Medical and Health Research Ethics, Southeast
Norway. Informed consent was implied by participation. The Regional
Committee for Medical Health Research Ethics approved that the study was
carried out without new consent from the participants.
Author details
1Oslo Centre for Biostatistics and Epidemiology, Institute of Basic Medical
Sciences, University of Oslo, Oslo, Norway. 2Department of Vaccines,
Norwegian Institute of Public Health, Oslo, Norway. 3Department of
Registration, Cancer Registry of Norway, Oslo, Norway. 4Department of
Pharmaco-epidemiology, Norwegian Institute of Public Health, Oslo, Norway.
5Department of Community Medicine, University of Tromsø, Tromsø, Norway.
6Department of Oncology, Oslo University Hospital, Oslo, Norway.
7Department of Nutrition, Institute of Basic Medical Sciences, University of
Oslo, Oslo, Norway.
Received: 12 January 2016 Accepted: 28 June 2016
References
1. World Cancer Research Fund/American Institute for Cancer Research.
Systematic literature review. Continuous update project report. The
association between food, nutrition and physical activity and the risk of
colorectal cancer. 2010.
2. Robsahm TE, Aagnes B, Hjartåker A, Langseth H, Bray FI, Larsen IK. Body
mass index, physical activity, and colorectal cancer by anatomical subsites: a
systematic review and meta-analysis of cohort studies. Eur J Cancer Prev.
2013;22:492–505.
3. Hursting SD, Berger NA. Energy balance, host-related factors, and cancer
progression. J Clin Oncol. 2010;28:4058–65.
4. Parekh N, Chandran U, Bandera EV. Obesity in cancer survival. Annu Rev
Nutr. 2012;32:311–42.
5. Dignam JJ, Polite BN, Yothers G, Raich P, Colangelo L, O’Connell MJ, et al.
Body mass index and outcomes in patients who receive adjuvant
chemotherapy for colon cancer. J Natl Cancer Inst. 2006;98:1647–54.
6. Hines RB, Shanmugam C, Waterbor JW, McGwin Jr G, Funkhouser E, Coffey
CS, et al. Effect of comorbidity and body mass index on the survival of
African-American and Caucasian patients with colon cancer. Cancer.
2009;115:5798–806.
7. Sinicrope FA, Foster NR, Sargent DJ, O’Connell MJ, Rankin C. Obesity is an
independent prognostic variable in colon cancer survivors. Clin Cancer Res.
2010;16:1884–93.
8. Meyerhardt JA, Tepper JE, Niedzwiecki D, Hollis DR, McCollum AD, Brady D,
et al. Impact of body mass index on outcomes and treatment-related
toxicity in patients with stage II and III rectal cancer: findings from
Intergroup Trial 0114. J Clin Oncol. 2004;22:648–57.
9. Ballian N, Yamane B, Leverson G, Harms B, Heise CP, Foley EF, et al. Body
mass index does not affect postoperative morbidity and oncologic
outcomes of total mesorectal excision for rectal adenocarcinoma. Ann Surg
Oncol. 2010;17:1606–13.
10. Adelstein BA, Macaskill P, Chan SF, Katelaris PH, Irwig L. Most bowel cancer
symptoms do not indicate colorectal cancer and polyps: a systematic
review. BMC Gastroenterol. 2011;11:65.
11. Lee J, Meyerhardt JA, Giovannucci E, Jeon JY. Association between body
mass index and prognosis of colorectal cancer: a meta-analysis of
prospective cohort studies. PLoS One. 2015;10:e0120706.
12. Campbell PT, Newton CC, Dehal AN, Jacobs EJ, Patel AV, Gapstur SM.
Impact of body mass index on survival after colorectal cancer
diagnosis: The Cancer Prevention Study-II Nutrition Cohort. J Clin Oncol.
2012;30:42–52.
13. Boyle T, Fritschi L, Platell C, Heyworth J. Lifestyle factors associated with
survival after colorectal cancer diagnosis. Br J Cancer. 2013;109:814–22.
14. Fedirko V, Romieu I, Aleksandrova K, Pischon T, Trichopoulos D, Peeters PH,
et al. Pre-diagnostic anthropometry and survival after colorectal cancer
diagnosis in Western European populations. Int J Cancer. 2014;135:1949–60.
15. Reichle K, Peter RS, Concin H, Nagel G. Associations of pre-diagnostic body
mass index with overall and cancer-specific mortality in a large Austrian
cohort. Cancer Causes Control. 2015;26:1643–52.
16. Maskarinec G, Harmon BE, Little MA, Ollberding NJ, Kolonel LN, Henderson
BE, et al. Excess body weight and colorectal cancer survival: the multiethnic
cohort. Cancer Causes Control. 2015;26:1709–18.
17. Campbell PT, Newton CC, Newcomb PA, Phipps AI, Ahnen DJ, Baron JA, et
al. Association between body mass index and mortality for colorectal
cancer survivors: overall and by tumor molecular phenotype. Cancer
Epidemiol Biomarkers Prev. 2015;24:1229–38.
Laake et al. BMC Cancer  (2016) 16:402 Page 9 of 10
18. Haydon AM, MacInnis RJ, English DR, Giles GG. Effect of physical activity
and body size on survival after diagnosis with colorectal cancer. Gut.
2006;55:62–7.
19. Doria-Rose VP, Newcomb PA, Morimoto LM, Hampton JM, Trentham-Dietz
A. Body mass index and the risk of death following the diagnosis of
colorectal cancer in postmenopausal women (United States). Cancer Causes
Control. 2006;17:63–70.
20. Prizment AE, Flood A, Anderson KE, Folsom AR. Survival of women with
colon cancer in relation to precancer anthropometric characteristics: the
Iowa Women’s Health Study. Cancer Epidemiol Biomarkers Prev.
2010;19:2229–37.
21. Pelser C, Arem H, Pfeiffer RM, Elena JW, Alfano CM, Hollenbeck AR, et al.
Prediagnostic lifestyle factors and survival after colon and rectal cancer
diagnosis in the National Institutes of Health (NIH)-AARP Diet and Health
Study. Cancer. 2014;120(10):1540–7.
22. Keum N, Greenwood DC, Lee DH, Kim R, Aune D, Ju W, et al. Adult weight
gain and adiposity-related cancers: a dose-response meta-analysis of
prospective observational studies. J Natl Cancer Inst. 2015;107.
23. Laake I, Thune I, Selmer R, Tretli S, Slattery ML, Veierød MB. A prospective
study of body mass index, weight change, and risk of cancer in the
proximal and distal colon. Cancer Epidemiol Biomarkers Prev.
2010;19:1511–22.
24. Bjartveit K, Foss OP, Gjervig T, Lund-Larsen PG. The cardio vascular disease
study in Norwegian counties. Background and organization. Acta Med
Scand Suppl. 1979;634:1–70.
25. Hsieh FY, Lavori PW. Sample-size calculations for the Cox proportional
hazards regression model with nonbinary covariates. Control Clin Trials.
2000;21:552–60.
26. World Health Organization. Obesity: Preventing and managing the global
epidemic. Report No 894. Geneva: WHO; 2000.
27. Park SM, Lim MK, Shin SA, Yun YH. Impact of prediagnosis smoking, alcohol,
obesity, and insulin resistance on survival in male cancer patients: National
Health Insurance Corporation Study. J Clin Oncol. 2006;24:5017–24.
28. Kuiper JG, Phipps AI, Neuhouser ML, Chlebowski RT, Thomson CA, Irwin ML,
et al. Recreational physical activity, body mass index, and survival in women
with colorectal cancer. Cancer Causes Control. 2012;23:1939–48.
29. Slattery ML, French TK, Egger MJ, Lyon JL. Diet and survival of patients with
colon cancer in Utah: Is there an association. Int J Epidemiol. 1989;18:792–7.
30. Guastadisegni C, Colafranceschi M, Ottini L, Dogliotti E. Microsatellite
instability as a marker of prognosis and response to therapy: A meta-
analysis of colorectal cancer survival data. Eur J Cancer. 2010;46:2788–98.
31. Campbell PT, Jacobs ET, Ulrich CM, Figueiredo JC, Poynter JN, McLaughlin
JR, et al. Case-control study of overweight, obesity, and colorectal cancer
risk, overall and by tumor microsatellite instability status. J Natl Cancer Inst.
2010;102:391–400.
32. Hughes LA, Williamson EJ, Van EM, Jenkins MA, Giles GG, Hopper JL, et al.
Body size and risk for colorectal cancers showing BRAF mutations or
microsatellite instability: a pooled analysis. Int J Epidemiol. 2012;41:1060–72.
33. Jensen MD. Role of body fat distribution and the metabolic complications
of obesity. J Clin Endocrinol Metab. 2008;93:S57–63.
34. Lovejoy JC, Champagne CM, De JL, Xie H, Smith SR. Increased visceral fat
and decreased energy expenditure during the menopausal transition. Int J
Obes (Lond). 2008;32:949–58.
35. Roberts DL, Dive C, Renehan AG. Biological mechanisms linking obesity and
cancer risk: New perspectives. Annu Rev Med. 2010;61:301–16.
36. Cole SR, Platt RW, Schisterman EF, Chu H, Westreich D, Richardson D, et al.
Illustrating bias due to conditioning on a collider. Int J Epidemiol.
2010;39:417–20.
37. Smits LJ, van Kuijk SM, Leffers P, Peeters LL, Prins MH, Sep SJ. Index event
bias-a numerical example. J Clin Epidemiol. 2013;66:192–6.
38. Wilsgaard T, Jacobsen BK, Schirmer H, Thune I, Løchen ML, Njølstad I, et al.
Tracking of cardiovascular risk factors: the Tromsø study, 1979-1995. Am J
Epidemiol. 2001;154:418–26.
39. Ulmer H, Kelleher C, Diem G, Concin H. Long-term tracking of cardiovascular
risk factors among men and women in a large population-based health
system: the Vorarlberg Health Monitoring & Promotion Programme. Eur Heart
J. 2003;24:1004–13.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Laake et al. BMC Cancer  (2016) 16:402 Page 10 of 10
